A quarter of eligible people have received their second booster shot against Covid, a "
clearly insufficient
" rate according to the government, which on Tuesday June 21 called on the oldest to receive the injection "
as soon as possible
", while a “
moderate epidemic recovery
” begins.
To discover
Find all the results of the legislative elections
Read alsoWould a reintegration of unvaccinated caregivers stem the emergency crisis?
"
It's not going fast enough, there are not enough people coming to be vaccinated
", worried the Ministry of Health during a press briefing.
To date, less than 2.2 million second boosters have been injected, out of more than 8.7 million eligible people – mainly those over 60, as well as the immunocompromised.
However, with almost 200,000 “
fourth dose
”, the past week has been the most prolific since the launch of the campaign in mid-March.
But the rule of six months since the first reminder inflates in parallel the eligible population, which will exceed 9 million at the beginning of July.
“Insufficient vaccination rates”
The concern is particularly acute for residents of nursing homes (48% of eligible vaccinated) and other people over the age of 80 (31%), who must "
get vaccinated as soon as possible to get through the summer and fall serenely
," insisted the ministry.
Also pointing to "
clearly insufficient vaccination rates
", Professor Alain Fischer, President of the Vaccine Strategy Guidance Council, stressed that the "
significant decrease
" in the protection generated by the first booster "
fully justifies
" a new dose .
in the oldest to "
protect them from serious forms until the fall
".
Read alsoCovid vaccine: is it possible that Pfizer has a disclaimer?
Especially since the “
moderate epidemic recovery
” observed in recent weeks (the number of cases has more than doubled in three weeks) “
is accompanied by a small resumption of hospitalizations
” and risks leading to “
a staggered increase in the time
” of critical care admissions and deaths, he noted.
All the more reason not to wait for new vaccines – especially those from Pfizer, Moderna, Sanofi and Hipra, he said – even if "
ideally they would be available at the time of the flu campaign
" for a new reminder at the end of the year.
